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Since several lines of evidence implicate the 3*-flank-
ing region in regulating a1(I) collagen gene transcrip-
tion, we analyzed 12.4-kilobase pairs of 3*-flanking
sequence of the murine a1(I) collagen gene for tran-
scriptional elements. A region of the 3*-flanking region
stimulated expression of the heterologous b-globin gene
promoter in an enhancer trap plasmid and of the a1(I)
collagen gene promoter in a collagen-luciferase reporter
gene construct when located 3* to the luciferase re-
porter gene. DNase I footprinting analysis demon-
strated the presence of three regions where DNA bind-
ing proteins specifically interact within this 3*-
stimulatory region. Inspection of the DNA sequence
revealed a consensus E-box, a binding site for basic he-
lix-loop-helix proteins, in one of the protein binding
sites. Mobility shift assays demonstrated that upstream
stimulatory factors (USF) USF-1 and USF-2 bind to this
E-box. Mutating the E-box in the context of the 3*-flank-
ing region confirmed that it contributes to the enhance-
ment of transcriptional activity of the a1(I) collagen
gene promoter. Mutations in all three protein binding
sites abolished transcriptional activation by the 3*-
flanking region, suggesting a complex interaction
among the trans-acting factors in enhancing transcrip-
tional activity. Thus, a region of the 3*-flanking region of
the a1(I) collagen gene stimulates transcription of the
a1(I) collagen gene promoter, and USF-1 and USF-2 con-
tribute to this transcriptional stimulation.
Type I collagen, the most abundant protein in vertebrates,
has diverse biological functions. It promotes cell migration,
differentiation, and tissue morphogenesis during development.
Additionally, it provides tensile strength to connective tissues
such as bone, tendons, and skin, and forms a supporting frame-
work of connective tissues in all major internal organs and the
vascular system. Type I collagen is also the major protein
produced during repair of tissue injuries and wound healing.
Excess deposition of type I collagen occurs in fibrogenic dis-
eases, such as hepatic fibrosis (1), pulmonary fibrosis (2), pri-
mary systemic sclerosis (3), and eosinophilic myalgia syndrome
(4). Type I collagen is the product of two genes, the a1(I) and
the a2(I) collagen genes, whose products form a heterotrimeric
protein composed of two a1(I) and one a2(I) polypeptide chains.
Although located on different chromosomes, both genes are
generally coordinately regulated in a developmental and tis-
sue-specific manner. Expression of the type I collagen genes is
active in many cell types and under various physiological con-
ditions, and their regulation is accordingly complex (5–8). Type
I collagen gene expression is also modulated by agents such as
cytokines and chemical or viral transformation.
Transcriptional regulatory elements have been previously
identified in the 59-flanking region, the promoter region, and
the first introns of both type I collagen genes in several species
(9–19). While sequences in the minimal promoter, within 220
bp1 upstream of the start site of transcription, appear to be
sufficient for the basal activity and partial tissue specificity of
the a1(I) collagen gene promoter in transient transfection as-
says, the precise function of distal 59-flanking sequences and
the first intron is less clear. Moreover, several lines of evidence
suggest that, in addition to these regulatory elements, se-
quences in the 39-flanking region may contribute to transcrip-
tional regulation of the a1(I) collagen gene. First, the 59-regu-
latory elements were not always sufficient for precisely
regulated, tissue-specific, high level expression of the gene
when tested in transient transfection experiments or in trans-
genic mice (10, 20–23). Second, in the transgenic HucII mouse
strain, a single copy of the human a1(I) collagen gene, which
included 1.6 kb of 59-flanking region, the entire structural gene,
and 20 kb of 39-flanking sequence, was expressed as efficiently
as the endogenous collagen gene in an appropriate tissue-
specific manner (24) and was induced appropriately during
hepatic fibrogenesis (7). Finally, the human a1(I) collagen gene
contains several DNase I-hypersensitive sites located immedi-
ately 39 of the structural gene (25), which are often indicative of
regulatory elements.
Therefore, we initiated a systematic analysis for regulatory
elements located within the 39-flanking region of the murine
a1(I) collagen gene. We located a segment of the 39-flanking
region which was found to enhance expression of the heterolo-
gous b-globin gene promoter as well as the endogenous a1(I)
collagen gene minimal promoter in NIH 3T3 fibroblast cells.
DNase I footprinting analysis demonstrated the location of
three sites of DNA-protein interactions within this transcrip-
tional stimulatory region. One of the binding sites contained a
consensus E-box, to which both USF-1 and USF-2, two basic
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helix-loop-helix proteins (bHLH), were found to bind. When the
E-box was mutated within the context of surrounding wild-type
39-flanking sequence, reduced levels of reporter gene activity
were observed. However, when all three cis-acting elements
were mutated a complete loss of transcriptional stimulatory
activity was obtained. These results demonstrate that tran-
scription of the a1(I) collagen gene is stimulated by a region
within the 39-flanking region of the gene and that USF-1 and
USF-2 participate in the stimulation of transcriptional activity
of the a1(I) collagen gene promoter.
MATERIALS AND METHODS
Plasmid Construction and DNA Sequencing—Fragments of the
genomic clones pCE4 and pCE5 (kindly provided by K. Harbers) which
contain the 39-flanking sequences of the murine a1(I) collagen gene (26)
(Fig. 1) were cloned into the unique SphI site of the enhancer trap
plasmid pbe2 (27). The entire a1(I) collagen sequence present in pCE5
was sequenced. This fragment contains the last 12 codons of the a1(I)
collagen gene. As a reference, the first base following the translational
stop codon is designated as 11. The complete genomic insert in pCE5
(4.6 kb) was cloned into pbe2, creating plasmid pbCE5, and a series of
deletions shown in Fig. 1B were created by digestion with Bal31 exo-
nuclease utilizing unique PstI and HindIII sites in the plasmid. The
plasmid pbCOL-(11899–4597) was created by digesting pbCE5 with
PstI, gel-purifying the large DNA fragment, and religating using T4
DNA ligase. A partial HincII digestion of the pCE4 genomic insert
produced two fragments (5.4 and 2.4 kb) which were individually cloned
into the SphI site of pbe2. The reporter gene pGLCOL3 was constructed
by ligating the a1(I) collagen promoter (2220 to 1116) into the BglII
and HindIII sites of the luciferase reporter gene pGL2-Basic (Promega,
Madison, WI). Reporter genes pCOL-(11899–4597) and pCOL(14597
to 1899) were constructed by ligating the 2698-bp 39 a1(I) collagen
fragment from plasmid pbCOL-(11899–4597) (Fig. 1) into the blunted
SalI site of pGLCOL3, which is located at the 39 end of the luciferase
gene, in both orientations. Plasmid pCOL-(11899–4597) contains the
39-flanking region in the 59 to 39 orientation, with respect to the direc-
tion of transcription from the collagen promoter, while in plasmid
pCOL-(14597 to 1899) the 39-flanking sequence is positioned 39 to 59,
with respect to the direction of transcription from the collagen pro-
moter. Plasmids pCOL-(13590–4597) and pCOL-(14597 to 3590) were
created by digesting pbCOL-(11899–4597) with HindIII and PstI,
blunting the ends of the isolated 1-kb fragment, and ligating the frag-
ment into pGLCOL3 which was digested with BamHI and the ends
blunted. This places the a1(I) collagen 39-flanking sequence 39 with
respect to the luciferase gene. Plasmids pCOL-(14090–4597) and
pCOL-(14597 to 4090) were constructed by generating a PCR product
using primers that hybridized to positions 14090 to 14113 (59-ATC
CGG ATC CGT AAC CTA AAG ATG GTG GGT TTT C-39) and positions
14597 to 14577 (59-ATC CGG ATC CGA ATT CCC ACT AGT GCG
GGG G-39) of the a1(I) collagen 39-flanking sequence. The PCR reaction
contained 10 mM Tris-HCl, pH 8.9, 50 mM KCl, 2.5 mM MgCl2, 2 mM
dNTPs, 1 mM each primer, 100 ng of pCE5 as the template, and 2.5 units
Taq DNA polymerase (Boehringer Mannheim). The reaction was cycled
as follows: 94 °C for 1 min, 60 °C for 1 min, 72 °C for 1 min for 30 cycles,
an extension incubation at 72 °C for 10 min, followed by incubation at
4 °C, using a GeneAmp PCR System 9600 (Perkin-Elmer). The PCR
fragment was digested with BamHI, using the BamHI recognition site
designed in the primers, and cloned into the BamHI site of pGLCOL3 in
both orientations. To construct plasmids containing the 39-footprinted
regions, oligonucleotides were synthesized and complementary strands
annealed. The annealed oligonucleotides were ligated together and the
ligation reaction subsequently electrophoresed in polyacrylamide gels.
Bands representing three and five copies of the ligated oligonucleotides
were excised and eluted from the gel. The oligonucleotides were then
ligated into the BamHI site of pGLCOL3. The oligonucleotides used for
the three footprinted regions were as follows, 39FP1 top strand: 59-GAT
CCG CGG CTG TCA CGT GGC ATG GGC TGG TAT GTG CTC TAA
ATA-39, bottom strand: 59-GAT CTA TTT AGA GCA CAT ACC AGC
CCA TGC CAC GTG ACA GCC GCG-39; 39FP2 top strand: 59-GAT CCT
CCT TTC CGC TGA CAT CAT TGC TGC CA-39, bottom strand: 59-GAT
CTG GCA GCA ATG ATG TCA GCG GAA AGG AG-39; and 39FP3 top
strand: 59-GAT CCC TTT GGG GAG GGA CCT GGA GCA A-39, bottom
strand: 59-GAT CTT GCT CCA GGT CCC TCC CCA AAG G-39. In
creating the construct p39FP1M, where the E-box was mutated while in
the context of surrounding wild-type 39-flanking sequence in plasmid
pCOL(13590–4597), the overlap extension method described by Ho et
al. (28) was used. Briefly, two oligonucleotides were synthesized which
contained the 6-bp mutation (underlined) (primer 1: 59-CAC CCC GCA
GCG GCT GTT GTA CAG CAT GGG CTG GTA TGT GCT-39; primer 2:
59-AGC ACA TAC CAG CCC ATG CTG TAC AAC AGC CGC TGC GGG
GTG-39). Two additional primers were synthesized which flanked the 59
end (primer 3: 59-ATC CGG ATC CTG CGC CTG AAA ATC TAT ACA
TAT AC-39) and 39 end (primer 4: 59-ATC CGG ATC CGA ATT CCC
ACT AGT GCG GGG G-39) of the a1(I) collagen 39-flanking sequence of
the pCOL-(13590–4597) insert. Two PCR reactions were performed
using the conditions as described above, one using primers 2 with 3 and
the second PCR reaction with primers 1 and 4. An aliquot of each PCR
reaction was combined in a second round PCR reaction along with
primers 3 and 4 using the same PCR conditions described above. The
product of this second PCR reaction was then digested with BamHI and
subsequently cloned into the BamHI site of pGLCOL3.
To mutate all three of the footprinted regions in the 39-flanking
region while in the context of plasmid pCOL-(13590–4597), a similar
mutagenesis approach, as described above, was utilized. The plasmid
p39FP1M was used as a template in PCR reactions using primers
designed to mutate 39FP2 (primer 1: 59-TGA ACC CAA GCC CTC CTT
TCT ATC AGT GCT GCC GCT GCC TTA AAT ACA GAT GCC-39;
primer 2: 59-GGC ATC TGT ATT TAA GGC AGC GGC AGC ACT GAT
AGA AAG GAG GGC TTG GGT TCA-39; the mutated nucleotides,
13797–3809, are underlined) along with the 59-flanking primer (primer
3 above) and 39-flanking primer (primer 4 above). After the second PCR
reaction the 39FP1 and 39FP2mutated fragment was used as a template
in PCR reactions to generate mutations in 39FP3 as described above
using 39FP3 M primers (primer 1: 59-TTG GAA TCC AAG TCC CTT
TGG AAG AAA GTT CGG AGC ATG GTC ACT CCT GG-39; primer 2:
59-CCA GGA GTG ACC ATG CTC CGA ACT TTC TTC CAA AGG GAC
TTG GAT TCC AA-39; the mutated nucleotides, 14050–4059, are un-
derlined) along with the 59-flanking primer (primer 3 above) and 39-
flanking primer (primer 4 above). After the second PCR reaction the
PCR product was digested with BamHI, gel-purified, and cloned into
pGLCOL3, digested with BamHI, creating p39FP1-2-3M.
DNA sequencing was performed by the dideoxy method using the
Sequenase version 2.0 kit (Boehinger Mannheim) according to the man-
ufacturer’s recommended protocol to confirm the presence of the muta-
tions in the respective footprinted regions.
Transfections and Reporter Gene Assays—NIH 3T3 fibroblast cells
and HeLa cells were cultured in 150-mm plates with Dulbecco’s mini-
mum essential medium (Life Technologies, Inc.) supplemented with
10% calf serum and grown in a 5% CO2, 95% air atmosphere at 37 °C.
Transfections using the b-globin reporter gene were performed using
the calcium phosphate precipitation method as described (13, 19). In
addition to 20 mg of the pbe2 based reporter gene constructs, each
transfection contained 20 mg of the pa reporter gene (27) which served
as an internal control for transfection efficiencies. Cells were treated
with 75 mM chloroquine during the transfection, and after 4 h the
transfection mixture was removed, and the cells were shocked for 1 min
using 10% glycerol. The cells were harvested 36–48 h after transfec-
tion, and total RNA was prepared by the acid-phenol method (29).
Radiolabeled antisense b-globin and a-globin RNA probes were gener-
ated by SP6 and T7 RNA polymerase, respectively. T7 transcription of
pa creates a 244-nucleotide transcript of which 131 nucleotides are
protected (30). SP6 transcription of pbe2 creates a 500-nucleotide tran-
script of which 350 nucleotides are protected (27). Total RNA samples
were analyzed by RNase protection assay as described (31), and a- and
b-globin transcripts were quantitated by scanning with an image ana-
lyzer or direct counting of the bands. Transient transfections using the
luciferase reporter gene plasmids were performed using Lipo-
fectAMINE (Life Technologies, Inc.). NIH 3T3 cells were seeded into
6-well dishes at a density of 9 3 104 cells per well. The day after seeding
0.5 mg of luciferase reporter plasmid, 0.5 mg of pRSV-bgal and 1.1 mg of
carrier DNA, pUC19, was added to the cells using 11 mg of Lipo-
fectAMINE reagent per well following the recommended protocol of the
manufacturer. Liposomes were incubated with the cells for 8 h. The
RSV-bgal reporter gene plasmid was co-transfected to normalize for
transfection efficiencies. Luciferase and b-galactosidase reporter gene
assays were performed as described previously 36–48 h after transfec-
tion (13, 19).
DNase I Footprinting and Mobility Shift Assays—DNase I footprint-
ing analysis and mobility shift assays were performed as described
previously (13). Nuclear proteins were obtained using the method de-
scribed by Schreiber et al. (32). Supershift assays were performed, as
described previously (13), using USF-1 and USF-2 polyclonal antibodies
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA). The oligonucleotides
used in the mobility shift assays representing 39FP1 were top strand:
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59-GAT CCG CTG TCA CGT GGC ATG GGC TGA-39; bottom strand:
59-GAT CTC AGC CCA TGC CAC GTG ACA GCG-39. The oligonucleo-
tides that contained a mutation within the consensus E-box, 39FP1M
were top strand: 59-GAT CCG CTG TTG TAC AGC ATG GGC TGA-39;
bottom strand: 59-GAT CTC AGC CCA TGC TGT ACA ACAGCG-39 (the
mutated nucleotides are underlined).
Oligonucleotides—Oligonucleotides were synthesized using a Cy-
clone Plus Oligonucleotide Synthesizer (Milligen, Novato, CA) and were
gel-purified after electrophoresis in 10% polyacrylamide gels.
DNA Sequence—The DNA sequence described in this paper has been
deposited into the GenBank data base.
RESULTS
The 39-Flanking Region of the a1(I) Collagen Gene Contains
a Region That Stimulates Transcription in an Enhancer Trap
Plasmid—To investigate the presence of transcriptional regu-
latory elements located in the 39-flanking region of the a1(I)
collagen gene, we cloned several fragments representing 12.4
kb of this region into the enhancer trap plasmid, pbe2 (27).
This plasmid contains the human b-globin promoter and struc-
tural gene with a unique SphI cloning site located 2.2 kb
downstream (or 3.3 kb upstream) of the b-globin transcrip-
tional start site. The recombinant plasmids were transiently
transfected into NIH 3T3 cells along with a plasmid containing
the human a-globin gene, to serve as an internal control for
transfection efficiency. The relative levels of b- and a-globin
mRNA were assessed by RNase protection assays using total
RNA from transfected cells. Insertion of the entire 4.6 kb
genomic fragment of pCE5 into the enhancer trap plasmid
stimulated the expression of the b-globin gene 1.7-fold com-
pared with expression of pbe2 alone, whereas a1(I) collagen
gene fragments derived from the pCE4 plasmid did not exhibit
any stimulatory effects on b-globin expression (Fig. 1A and
summarized in Fig. 1B). Therefore, we concentrated our efforts
on a1(I) collagen 39-flanking sequences in pCE5 to further
localize the position of the enhancing activity using deletional
analysis. Fig. 1B summarizes the results of two to six transfec-
tion experiments carried out with independently purified plas-
mid preparations. The smallest construct containing enhancing
activity was pbCOL-(12643–4597) which reproducibly stimu-
lated b-globin expression 2.8-fold as compared to pbe2. This
level of stimulation by the a1(I) collagen 39 fragment is com-
parable with the stimulation of pbe2 by the strong SV40 early
gene enhancer in NIH 3T3 cells (27). To eliminate the possibil-
ity that the expression of the a-globin gene interferes with or
affects the b-globin expression, the b-globin constructs were
also transfected alone in a separate experiment with identical
results (data not shown).
To determine whether this enhancing activity is cell type-
specific, transient transfections were performed using the same
reporter gene constructs in HeLa cells, which express no or low
levels of type I collagen (33). None of the a1(I) collagen 39-
flanking genomic sequences stimulated b-globin gene expres-
sion in HeLa cells (Fig. 1C). In fact, the a1(I) collagen derived
fragments in plasmids pbCOL-(11899–4597) and pbCOL-
(12643–4597) had a slight inhibitory effect on b-globin gene
expression relative to the control pbe2 plasmid in these cells.
The a1(I) Collagen Gene 39-Flanking Region Stimulates Ex-
pression of the a1(I) Collagen Gene Promoter—Since a segment
of the a1(I) collagen gene 39-flanking region stimulated expres-
sion from the heterologous b-globin promoter, we wanted to
determine if this region could also stimulate expression from
the homologous a1(I) collagen gene promoter. Therefore, we
cloned the a1(I) collagen genomic insert from the plasmid
pbCOL-(11899–4597) in both orientations, behind the lucifer-
ase reporter gene in pGLCOL3, in which the luciferase gene is
driven by the a1(I) collagen minimal promoter (2220 to 1116),
creating the plasmids pCOL-(11899–4597) and pCOL-(14597
to 1899) (Fig. 2A). When these plasmids were transiently trans-
fected into NIH 3T3 cells, and transfection efficiencies were
normalized by co-transfection with pRSV-bgal, a significant
increase in transcriptional activity of the a1(I) collagen pro-
moter was observed when the 39-flanking sequence was in the
59 to 39 orientation. However, when positioned in the opposite
orientation (39 to 59) an inhibitory effect was observed (Fig. 2B)
indicating the presence of an inhibitory element. To further
localize the stimulatory element within the a1(I) collagen 39-
flanking region, the shorter collagen sequence in pbCOL-
(13590–4597) was inserted behind the luciferase reporter
gene in the pGLCOL3 plasmid, in both orientations, creating
the plasmids pCOL-(13590–4597) and pCOL-(14597 to 3590)
(Fig. 2A). Transient transfections with these plasmid con-
structs into NIH 3T3 cells also demonstrated a stimulatory
effect of this region on the a1(I) collagen gene promoter when
FIG. 1. The 3*-flanking region of the a1(I) collagen gene con-
tains a region that enhances transcription from a heterologous
promoter. A, NIH 3T3 cells were transiently transfected by the calci-
um-phosphate method and expression levels transfected the plasmids
determined by RNase protection assays. The plasmid, pa, was used as
an internal reference to normalize for transfection efficiency. Several
independent plasmid preparations gave the same results of b-globin
transcriptional activation. B, summary of expression of pbe2-derived
plasmids in NIH 3T3 cells. The first line shows the 39 region of a1(I)
collagen with stop codon, polyadenylation sites, the last exon (stippled
box), and selected restriction sites. The 4.6- and 7.8-kb fragments con-
tained in pCE5 and pCE4 plasmids, respectively, are shown in the
second line. The fragments used in transfection assays and the levels of
b-globin RNA expressed relative to the level produced by the enhanc-
erless pbe2 plasmid and corrected for transfection efficiency by normal-
izing for a-globin mRNA levels are shown. C, HeLa cells were tran-
siently transfected by the calcium-phosphate method with the indicated
plasmids, and RNase protection assays were performed as with NIH
3T3 cells.
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positioned in either orientation (Fig. 2B). However, further
deleting 39-flanking sequence to nucleotides 14090 to 14597
(plasmids pCOL-(14090–4597) and pCOL-(14597 to 4090))
eliminated the stimulatory effect. Together, these data indicate
that a transcriptional stimulatory element located in the a1(I)
collagen gene 39-flanking region is positioned between nucleo-
tides 13590 to 14089.
DNA Binding Proteins Specifically Interact at Three Loca-
tions within the a1(I) Collagen Gene 39-Flanking Region—To
determine the locations of DNA binding proteins in this stim-
ulatory element in the 39-flanking region of the a1(I) collagen
gene, we performed DNase I footprinting analysis using NIH
3T3 nuclear extracts. Three sites of specific DNA-protein inter-
actions were located and called 39FP1, 39FP2, and 39FP3 (Fig.
3A, left, middle, and right, respectively; and summarized in
Fig. 3B). To determine the effect that each of the footprinted
regions exerts on expression of the a1(I) collagen promoter
region, we cloned one copy, in both orientations, as well as
three and five copies of the oligonucleotides representing each
footprint into the BamHI site of pGLCOL3. We investigated
single and multiple copies of the binding sites in order to
optimize their effects on transcriptional activation. The plas-
mid constructs were transiently transfected into NIH 3T3 cells
and transfections normalized to the activity of the co-trans-
fected pRSV-bgal plasmid. Although no stimulatory effect on
transcriptional activity of the a1(I) collagen gene minimal pro-
moter was observed when one copy of 39FP1 was present in
either orientation, the 39FP1 sequence stimulated expression
nearly 4-fold when three copies were present and approxi-
mately 6-fold when five copies were present (Fig. 4). On the
other hand, 39FP2 slightly stimulated expression of the a1(I)
collagen gene promoter with only one copy present but not with
five copies (Fig. 4). 39FP3 slightly stimulated expression of the
parental pGLCOL3 plasmid when either a single copy or with
three copies of the footprinted regions were positioned 39 of the
luciferase reporter gene (Fig. 4).
USF-1 and USF-2 Interact at a Consensus E-box Binding
Site Located in the a1(I) Collagen 39-Flanking Region—Since
39FP1 stimulated expression of the a1(I) collagen gene minimal
promoter, we wished to identify the protein(s) that interacts
with this cis-acting element. Mobility shift assays were per-
formed with a radiolabeled 39FP1 oligonucleotide using NIH
3T3 nuclear extracts. A DNA-protein complex was formed in
the mobility shift assay (Fig. 5, lane 2) which was specifically
competed with cold unlabeled 39FP1 oligonucleotide (Fig. 5,
lane 3). Examination of the nucleotide sequence of 39FP1 dem-
onstrated a consensus E-box (CANNTG), a known binding site
for bHLH proteins (34), located at nucleotide 13695 to 13700
in the a1(I) collagen 39-flanking sequence. To determine if the
consensus E-box is involved in protein binding to 39FP1, we
used a mutated 39FP1 oligonucleotide in which the six nucleo-
tides representing the consensus E-box were mutated in the
context of surrounding wild-type sequence. This mutated oli-
gonucleotide failed to compete for protein binding (Fig. 5, lane
4) demonstrating that the E-box is required for protein binding
to the 39FP1 footprint sequence. The nucleotide sequence of
this E-box matches the USF-1/USF-2 consensus binding site
(CACGTG) (35). Therefore, we used antibodies directed against
USF-1 or USF-2 in the mobility shift assay to test if these two
bHLH proteins interact with 39FP1. Addition of either the
USF-1 or the USF-2 antibody in the binding reaction super-
shifted the DNA-protein complex (Fig. 6, lanes 4 and 5), with
the USF-1 antibody supershifting the complex to a greater
degree than the USF-2 antibody. When both antibodies were
included in the binding reaction (Fig. 6, lane 6), the entire
complex was eliminated indicating that both USF-1 and USF-2
interact with 39FP1 as either homodimers or heterodimers.
Additionally, binding to 39FP1 requires Mg21 for binding with
maximal binding activity requiring at least 5 mM MgCl2 (data
not shown). This is in agreement with a previous report dem-
onstrating that decreased Mg21 concentration reduces binding
affinity of USF-1 to DNA (36). Binding activity of USF-1/USF-2
to 39FP1 was not salt-dependent as binding occurs over a wide
range of salt concentrations (26 to 200 mM NaCl) in the binding
reaction (data not shown).
USF Participates in the Activation of the a1(I) Collagen Gene
Promoter—To determine the functional role of USF interaction
with this 39 E-box in the stimulatory effect of the 39-flanking
region on the a1(I) collagen gene promoter, we generated a
mutated reporter gene construct in which only the CACGTG
(nucleotides 13695 to 13700) E-box site was mutated in
pCOL-(13590–4597) (see Fig. 2A), creating p39FP1M. When
p39FP1M was transiently transfected into NIH 3T3 cells and
transfection efficiencies normalized to the co-transfected
pRSV-bgal plasmid, a significant decrease in reporter gene
activity was observed compared with the wild-type parental
pCOL-(13590–4597) plasmid (Fig. 7). This indicates that at
least part of the stimulatory properties of this region on the
a1(I) collagen gene promoter are due to USF-1/USF-2 binding
FIG. 2. The 3*-flanking region of the a1(I) collagen gene stim-
ulates transcription from the a1(I) collagen gene promoter. A,
general structure of reporter genes containing the a1(I) collagen pro-
moter-luciferase reporter gene and a1(I) collagen 39 sequence. The
specific a1(I) collagen 39 sequence used in each construct is designated
below. B, plasmids were transfected into NIH 3T3 cells by the lipofec-
tion method and relative luciferase activity normalized to the activity of
the co-transfected pRSV-bgal plasmid. Data represent the average of at
least eight transfections. Those plasmids in which the activity was
significantly different compared with pGLCOL3, using the Wilcoxan
signed ranks statistical analysis, are designated by an asterisk;
p , 0.05. Error bars represent S.E.
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to the E-box. To assess if the other footprinted regions, 39FP2
and 39FP3, participate in the stimulatory properties in the
pCOL-(13590–4597) plasmid, we created plasmid p39FP1–
2-3M which contained mutations in all three footprinted re-
gions (nucleotides 13695–3700; nucleotides 13797–3809; nu-
cleotides 14050–4059). When this plasmid was transiently
transfected into NIH 3T3 cells, a complete inhibition of tran-
scriptional activation was observed and, in fact, resulted in a
reduction of expression compared with the parental pGLCOL3
plasmid (Fig. 7). This result supports data presented in Fig. 2B
demonstrating an inhibitory element is present as shown in
plasmid pCOL-(14597 to 1899). Taken together, these data
indicate that USF-1/USF-2 is involved in the stimulatory prop-
erties of the 39-flanking region on the a1(I) collagen gene pro-
moter; however, 39FP2 and 39FP3 also cooperate in stimulating
transcription of the a1(I) collagen gene promoter.
DISCUSSION
The genes encoding the a1 and a2 polypeptide chains of type
I collagen are regulated in a developmental, inducible, and
tissue-specific manner. In previous studies of the human, mu-
rine, and rat a1(I) collagen genes using either transient trans-
fections into cultured cells or transgenic animals, cis-regula-
tory elements have been identified in the 59-flanking regions,
the promoter region, and first introns of these genes (9–19).
The precise functions of many of these cis-acting elements
remain to be elucidated, and some conflicting results have been
reported, perhaps reflecting the use of different reporter gene
constructs and different cell types. Most studies support the
notion that the 59 region of the a1(I) collagen gene contains a
strong proximal promoter which exhibits at least partial tissue
specificity and which is modulated by additional regulatory
elements.
Several lines of evidence suggested that the 39-flanking re-
gion of the a1(I) collagen gene contains transcriptional regula-
tory elements. Therefore, we initiated a systematic analysis of
the 39-flanking region to locate important regulatory elements.
Our analysis of the 39-flanking region of the a1(I) collagen gene
has located a fragment (between nucleotides 11899 to 14597
FIG. 3. The 3*-flanking region of the a1(I) collagen gene contains the binding sites for three DNA binding proteins. A, DNase I
footprinting assays were performed using nuclear extracts obtained from NIH 3T3 cells and incubated with radiolabeled probes from the
39-flanking region of the a1(I) collagen 39-flanking region. DNase I footprinting assays were performed as described under “Material and Methods.”
G 1 A reactions were performed to locate the specific regions where proteins bind. Bovine serum albumin (BSA), 20 mg, was used to compare the
banding pattern with nonspecific proteins. The footprint reactions for 39FP1, 39FP2, and 39FP3 are positioned right, middle, and left, respectively.
B, the locations of each of the three footprinted regions are underlined in the nucleotide sequence of the a1(I) 39-flanking region. 39FP1 is between
nucleotides 13690 and 3710; 39FP2 is between nucleotides 13790 and 3815; 39FP3 is between nucleotides 14045 and 4064.
FIG. 4. 3*FP1 stimulates expression of the a1(I) collagen gene
promoter in NIH 3T3 cells. Each of the 39-footprinted regions were
cloned behind the luciferase gene in the pGLCOL3 plasmid with either
one copy, in both orientations, three, or five copies. Each construct was
transiently transfected into NIH 3T3 cells and luciferase activity meas-
ured and normalized to the activity of the co-transfected pRSV-bgal
plasmid. Data represent the average of four transfections. Those plas-
mids in which the activity was significantly different compared to
pGLCOL3, using the Wilcoxan signed ranks statistical analysis, are
designated by an asterisk; p , 0.05. Error bars represent S.E.
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downstream of the translational termination site of the a1(I)
collagen gene) that enhances transcription of the heterologous
b-globin gene promoter in NIH 3T3 cells, a cell line that ex-
presses moderate levels of type I collagen. Although the level of
enhancement is not dramatic, it is comparable to the enhance-
ment of the same reporter gene construct by the SV40 enhancer
in the same cells (27). This fragment also stimulates transcrip-
tion driven by the a1(I) collagen promoter in an orientation-de-
pendent manner. Deletional analysis of the 39-stimulatory
region narrowed the enhancing region to within a 500-bp seg-
ment. DNase I footprinting assays demonstrated the presence
of three regions that specifically interact with DNA binding
proteins. Only one of the footprinted regions was capable of
stimulating expression of the a1(I) collagen promoter when
multiple copies were inserted 39 of the luciferase reporter gene.
Further analysis of this protein binding site demonstrated that
both USF-1 and USF-2 interact with the nucleotide sequence of
a consensus E-box, the binding site for basic helix-loop-helix
(bHLH) proteins. A functional role of this site in stimulating
expression of the a1(I) collagen gene promoter was assessed by
mutating only the nucleotides comprising the consensus E-box
while in the context of the wild-type pCOL-(13590–4597) col-
lagen containing sequence. The mutated collagen-luciferase
reporter gene construct containing the mutated E-box had de-
creased transcriptional activity compared with the wild-type
E-box. However, the transcriptional stimulatory properties of
the 39-flanking region was completely lost only when all three
protein binding sites were mutated. This was surprising since
39FP2 and 39FP3 alone did not stimulate transcription (Fig. 4).
These data suggest a complex interaction between the trans-
acting factors interacting with the 39-flanking region. In addi-
tion, when all three cis-acting elements were mutated, pro-
moter activity was reduced compared with to the level of the
a1(I) promoter-driven plasmid pGLCOL3. This indicates that a
negative regulatory element is present between nucleotides
13590 and 4597. This finding is supported in the construct
pCOL-(14597 to 1899) where an inhibitory effect was observed
on transcriptional activity (see Fig. 2).
The USF-1 binding site in the endogenous a1(I) collagen
gene is located over 20 kb downstream from the promoter.
Regulatory elements have also been demonstrated in the 39-
flanking region of several other genes, including the mouse
cytosolic glutathione peroxidase gene (37), the human keratin
19 gene (38), the murine c-fos protooncogene (39), the human
angiotensinogen gene (40), and the human tyrosine hydroxy-
lase gene (41). One could speculate that looping of the chroma-
tin would place the two regions in close enough proximity to
one another for appropriate interactions to occur.
Both USF-1 and USF-2 are ubiquitously expressed, although
their relative abundance varies in different cell types (42). In
fact, USF was originally identified and characterized in HeLa
cells (43–45). Thus, it was surprising that the 39 region of the
a1(I) collagen gene enhanced transcription in NIH 3T3 cells
but not in HeLa cells. Perhaps differences in the USF proteins,
transcriptional co-factors, or other DNA binding proteins allow
for this difference in transcriptional activity between the two
cell types. The expression of both USF-1 and USF-2 genes
results in multiply spliced messages producing variations in
the amino terminus of the protein (42). This, therefore, may
give rise to proteins with different transcriptional stimulating
FIG. 5. Protein binding to 3*FP1 requires an intact consensus
E-box. The mobility shift assay was performed using a radiolabeled
probe representing 39FP1 and 10 mg of NIH 3T3 nuclear extract. A
specific DNA-protein complex is formed with the wild-type (wt) 39FP1
oligonucleotide used in the mobility shift assay (lane 2), which is effi-
ciently competed with wild-type unlabeled oligonucleotide (lane 3). A
mutant (mut) 39FP1 oligonucleotide, in which the consensus E-box is
mutated, fails to compete for protein binding (lane 4). Lane 1 is the
probe incubated without nuclear extract. A 100-fold molar excess of
unlabeled oligonucleotides was used in the competition reactions.
FIG. 6. Both USF-1 and USF-2 bind to 3*FP1. A mobility shift
assay was performed using 39FP1 as a radiolabeled probe and incubated
with 10 mg of NIH 3T3 nuclear extract (lanes 2–6). Lane 1 is the probe
incubated without nuclear extract. A 100-fold molar excess of unlabeled
39FP1 oligonucleotide was used as a competitor in the binding reaction
(lane 3). Supershift studies were performed using either a polyclonal
USF-1 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in
the binding reaction (lanes 4 and 6) or a polyclonal USF-2 antibody
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in the binding reac-
tion (lanes 5 and 6).
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activities since the amino-terminal portion of the proteins con-
tain the trans-activating domain. Since the USF family mem-
bers homodimerize and heterodimerize with each other, but do
not heterodimerize with other bHLH proteins (46, 47), various
ratios of multiple USF-1 and USF-2 proteins will generate
complex sets of USF members with potentially different tran-
scriptional activating capacities. Additionally, transcriptional
co-factors may be absent in the HeLa cells that are necessary
for USF to stimulate the a1(I) collagen gene promoter. USF
does not appear to trans-activate effectively in highly purified
in vitro systems (48) suggesting a role for additional interacting
proteins. It is believed that USF-1 affects transcription by
interacting with the multisubunit TFIID complex (43, 49) and
specifically with the TFIID subunit TAFII55 (50). Additional
factor(s) also appear to be required for USF to stimulate tran-
scription, one of which appears to be PC5, a novel co-factor
which has been demonstrated to mediate transcriptional acti-
vation by USF-1 (51).
USF contributes to the regulation of multiple genes, some of
which are expressed in a tissue-specific or inducible manner.
The human b-globin locus control region (52), the murine type
IIb regulatory subunit gene of cyclic adenosine 39,59-monophos-
phate-dependent protein kinase gene (53), the murine p53 gene
(54), the human cell cycle-dependent cyclin B1 gene (55), the
chicken aA-crystallin gene (56), the rat cardiac ventricular
myosin light chain 2 gene (57), and the rat preprotachykinin-A
gene (58) are regulated in part by USF. USF has also been
shown to be involved in the TGF-b1 responsive element in the
human plasminogen activator inhibitor gene (59) and in the
glucose responsive element in the pyruvate kinase gene (60).
Our study demonstrates that the ubiquitous USFs contribute
to the moderate high transcriptional rate of the a1(I) collagen
gene in NIH 3T3 cells.
The present study, in conjunction with previous studies,
demonstrates that the a1(I) collagen gene is regulated by a
complex array of cis-acting elements in the 59-flanking region,
the promoter, the first intron, and 39-flanking region. Like
USF-1 and USF-2, which interact with the 39-regulatory ele-
ment identified in this study, most of the other factors involved
in transcriptional regulation of the a1(I) collagen gene are
ubiquitous factors. For example, the proximal promoter has
been shown to interact with SP1, NF-I, CBF, and cKrox (13, 61,
62), none of which is present exclusively in collagen-producing
cells. Several elements, however, have been shown to contrib-
ute to cell-specific expression of the a1(I) collagen promoter.
These include a TGF-b response element located approxi-
mately 1.6 kb upstream of the transcriptional start site (63), a
sequence required for expression in bone (64) and elements
that modulate expression in dermal fibroblasts, osteoblasts,
and odontoblasts, and in tendon and fascia fibroblasts (65).
However, even without these elements the a1(I) collagen pro-
moter exhibits a remarkable degree of tissue specificity (10, 65,
66). Taken together, these observations suggest that the vari-
ous regulatory elements located in the 59-flanking region, the
first intron, the 39-flanking region, and possibly additional sites
so far unidentified act in concert to provide appropriate tissue
specificity and high levels of activity of the a1(I) collagen gene
promoter and that the correct spatial arrangement of the var-
ious elements is required for appropriate activity.
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